---
title: "Cosmetic Formula Ownership"
description: "Work out who owns, may use and may share a cosmetic formula. Includes a rights table, transfer-package list and questions to take to your lawyer."
image: "https://cosmetic-labs.com/wp-content/uploads/67010-cosmetic-formula-ownership-1200x1200-1.webp"
---
# Cosmetic Formula Ownership

> Work out who owns, may use and may share a cosmetic formula. Includes a rights table, transfer-package list and questions to take to your lawyer.

Source: https://cosmetic-labs.com/articles/cosmetic-formula-ownership
Created: 2026-10-23T17:32:26+00:00
Modified: 2026-10-25T15:34:49+00:00
Author: Emilie SCHOL

Cosmetic Formula Ownership | Cosmetic Labs

## **Key takeaways**

Ownership, a licence to use information, exclusivity and access to documents are separate questions. Record each explicitly.

Identify existing supplier material, commissioned outputs, later changes and third-party dependencies instead of treating “the formula” as one undefined asset.

Access for safety assessment does not settle what a receiving manufacturer may receive or use. Do not assume that payment or an NDA establishes ownership or transfer rights.

Plan practical transfer deliverables alongside legal permissions. Documents alone do not guarantee that another manufacturer can reproduce the product.

Who owns a cosmetic formula depends on the agreements you signed, the rights involved and the law that applies. A development invoice or the word “custom” on a quote won’t settle it. Ask four questions separately: who owns what, which uses are permitted, who may receive confidential information and what you would need to move production to another manufacturer.

This guide helps founders prepare those questions for a qualified lawyer and for technical reviewers. Interpreting your agreement is a job for your lawyer. The [cosmetic product development roadmap](https://cosmetic-labs.com/cosmetic-product-development-guide) shows which commitments depend on the answers.

## Before you negotiate: list what your business needs to do
“We want to own the formula” is a hard request to negotiate or advise on. A list of the things you need to be able to do is easier to work with. Your lawyer can then tell you which rights or commitments would support each one.

Decide whether you need to:

Manufacture only through the current supplier, or also through another one.
- Commission changes to the formula and use the new versions.
-  confidential information with safety assessors, testing providers or other specialists.
- Obtain specific reports and keep access to them if the supplier relationship ends.
- Get technical help for a new manufacturer.
- Stop the supplier or others from using the formula in specified ways.
Mark each item essential, preferred or undecided, and note which commitment depends on it. If you are still choosing between a stock base and a new formula, the [private label versus custom formulation comparison](https://cosmetic-labs.com/private-label-vs-custom-formulation) covers that choice.

## Step 1: Separate ownership, permission, exclusivity and access
Owning an asset and being allowed to use it are different things. [WIPO’s page on IP assignment and licensing](https://www.wipo.int/en/web/business/assignment-licensing) describes assignment as the sale of an IP asset, transferring ownership to another party. Licensing lets another party use the IP while the owner keeps it. WIPO describes these in general terms; which rights protect your formula, and who holds them, is a question for your lawyer.

The same WIPO page notes that licences can be sole, exclusive or non-exclusive. Labels like these vary between agreements, so ask your lawyer to spell out what the proposed terms let the supplier, your brand and anyone else do.

Fill in this table from the documents you have and send the open rows to your lawyer:

TopicQuestion to resolveRecord to identifyOwnership or assignmentWhich asset or right is involved, and who holds it under the documents?Asset reference, parties and relevant clausesLicence or other permissionWhat may your brand and its appointed providers do, and with what restrictions?Permitted uses, recipients and open limitsExclusivityWhat is the supplier or anyone else prevented from doing, and what falls outside that?Defined subject matter and scopeFormula accessWho receives which formula information, in what form and for what purpose?Version, recipient, disclosure and use termsDossier and report accessWhich records can your brand and its specialists obtain and use?Document register, access route, access after the contract endsManufacturing know-howWhich process information and help are included or excluded?Technical deliverables, restrictions and dependenciesTransfer supportWhat can a new manufacturer receive and use, and what help is agreed?Transfer package, responsibilities and acceptance processAnswer each row on its own terms. Getting access to documents, for instance, leaves open whether another manufacturer may use them. To check whether a supplier can deliver in practice, use the [supplier due-diligence checklist](https://cosmetic-labs.com/how-to-choose-a-cosmetic-lab).

## Step 2: List existing material and new work separately
A project can draw on a supplier’s existing base, new development work, process information and third-party material, and each may come with different terms. Before negotiating who holds what, write down what each item is.

Here, “existing material” means anything that existed before the project or was brought into it, and “new work” means the deliverables you are asking the provider to create. Your agreement may use other terms, so ask your lawyer to match them up.

For each item, record:

- **Item and version:** starting formula, revised formula, specification, report or process document.
- **Origin:** supplied by your brand, an existing supplier item, new work or third-party material.
- **Proposed terms:** who claims to own it, what permissions are proposed and how it may be disclosed. Note these as claims until reviewed.
- **Dependencies:** other information or permissions needed to use it.
- **Changes:** how later improvements and new versions will be identified and handled.
- **Open issue:** an owner, and the commitment on hold until it is resolved.
Give the ingredient list, quantitative formula, manufacturing instructions and test reports separate entries when their access or use terms differ, and check what each one actually contains. If an offer builds new work on an existing base, list both. Paying for the new work may leave ownership of the base unchanged, so ask how the documents treat each.

## Step 3: Agree who can receive and use confidential information
[WIPO’s trade secrets page](https://www.wipo.int/en/web/trade-secrets) describes trade secrets as IP rights on confidential information that can be sold or licensed, and lists formulas and recipes among its examples. In general, WIPO says, the information must be commercially valuable because it is secret, known only to a limited group, and protected by reasonable steps such as confidentiality agreements. It also notes that protection depends on the legal system and that whether it has been violated turns on the facts of each case.

A confidentiality agreement (NDA) governs disclosure. Whether it also affects ownership or lets you use another manufacturer depends on its terms, so ask your lawyer to read it alongside the permissions you need.

For each recipient, ask:

- What information do they need, and for which task?
- Who may disclose it to them, and on what terms?
- What may they do with it, and may they pass it on?
- What access will be needed later, including after the relationship ends?
- What happens if the recipient or manufacturing site changes?
A supplier may agree to send the formula directly to your safety assessor while saying nothing about a future manufacturer. Record both positions. The [supplier checklist](https://cosmetic-labs.com/how-to-choose-a-cosmetic-lab) helps you test whether the access arrangements work in practice.

## Step 4: Specify a usable manufacturing transfer package
Moving production raises three questions: are you permitted to, will you receive the information, and can the new team use it? Permission without the documents leaves you stuck, and documents without permission leave you exposed. Discuss this list with your lawyer and both technical teams:

- **Formula identity and content:** current version, quantitative composition where agreed, and the ingredient or raw-material references needed to read it.
- **Material specifications:** agreed specifications, supplier references and any restricted information that affects sourcing.
- **Manufacturing documentation:** agreed process instructions and records, with exclusions and dependencies identified by technical reviewers.
- **Product and pack specifications:** bulk, finished-product, filling and component references within the agreed scope.
- **Supporting evidence:** named reports, who may receive and use them, and a technical view on whether they apply to the new setup.
- **Version and change history:** approved versions, deviations, open issues and how later changes will be notified.
- **Technical assistance:** what help the supplier provides, how questions are handled and how gaps will be filled.
- **Delivery and acceptance:** format, delivery conditions, receiving reviewers and how incomplete items are recorded.
Ask the receiving team to say what is still unknown. A complete file list can still leave gaps in content, and earlier test results may need re-checking on a new site or process. The [scale-up guide](https://cosmetic-labs.com/cosmetic-formulation-scale-up) covers that technical handover. If switching manufacturer is essential to you, raise it during [supplier due diligence](https://cosmetic-labs.com/how-to-choose-a-cosmetic-lab), before you sign a manufacturing commitment.

## Step 5: Take the open questions to your lawyer
Give your lawyer the full document set and your list of required uses: proposal, development and manufacturing agreements, confidentiality terms, schedules and anything incorporated by reference. A supplier’s summary of who owns what is a useful extra but no substitute. The territory, term and exit prompts below are planning questions, not WIPO rules or model clauses.

PROJECT / FORMULA VERSION / REVIEW DATE:
BUSINESS DECISION AND PROPOSED COMMITMENT:
DOCUMENTS AND VERSIONS FOR COUNSEL:

RIGHTS AND SUBJECT MATTER
- What identified material and rights does each provision cover?
- How are background material, new outputs and later changes treated?
- What ownership, assignment or permission does counsel find supported?
- Which third-party rights or restrictions need clarification?

SCOPE OF USE
- Which products, uses, recipients and manufacturing arrangements are covered?
- What territory, term and exclusivity are proposed?
- Can an appointed manufacturer receive and use the necessary information?
- What conditions, approvals or restrictions remain unresolved?

CONFIDENTIALITY AND ACCESS
- How do permitted disclosures align with confidentiality obligations?
- Can the relevant assessors and other specialists obtain needed records?
- What access and permitted use are intended after termination?
- What return, deletion or continuing-record questions need resolution?

DELIVERY, CHANGE AND EXIT
- Are the deliverables identified and consistent across documents?
- What conditions affect their delivery or use?
- How are missing items, changes and transfer assistance addressed?
- What happens on termination or supplier inability to continue?
- Which applicable-law and dispute provisions need advice?

DECISION
- Open issue / legal or technical owner / next action:
- Commitment held pending resolution:
- Evidence and decision authority needed to clear the hold:
Ask your lawyer to flag contradictions and gaps as well as answering your questions. Ask the technical reviewers, separately, whether the promised deliverables would meet your needs.

## Step 6: Record what is agreed and what is on hold
Keep supplier statements apart from reviewed conclusions in your records. The example below is invented. It shows how to record an open question about switching manufacturer:

**Project:** moisturizer M01, formula F03; record R01.
**Business requirement:** confirm that another manufacturer could be used before signing the proposed manufacturing agreement.
**Information received:** the supplier proposal allows confidential formula disclosure to the appointed safety assessor. It does not mention disclosure to, or use by, another manufacturer.
**Open questions:** what permissions would cover another manufacturer, and what technical information and help would be available?
**Legal follow-up:** procurement lead to send the full document set and required uses to the brand’s lawyer.
**Technical follow-up:** technical coordinator to draft a transfer-package scope for review by any prospective manufacturer.
**Decision:** continue discussions; hold the manufacturing commitment until the switching question is answered.
**Reopen when:** legal and technical reviewers have answered the open questions and the decision owner records whether the arrangement meets the requirement.

The [development stage gates](https://cosmetic-labs.com/cosmetic-product-development-guide#stage-gates) help separate permission to keep talking from authorization to manufacture or launch.

## Where to start
Fill in the required-uses list, then the rights table, using the documents you already hold. Every blank row is a question for your lawyer or supplier, and the answers will tell you whether the arrangement on offer lets you do what your business needs.

*The WIPO guidance describes IP concepts in general terms and does not set ownership rules for any particular country or contract.*

Author: Emilie SCHOL    Founder of Cosmetic Labs, the B2B platform connecting cosmetic brands with labs, CROs and raw-material suppliers. Former Business Development Manager at QIMA Life Sciences (cosmetic & pharma CRO). Based in Toulouse, France.

Updated on

October 25, 2026

First posted on

October 23, 2026
Sources
## Sources and references
References supporting this page are listed below. Source access dates and supported claims are recorded in the evidence notes where available.
[IP Assignment and Licensing](https://www.wipo.int/en/web/business/assignment-licensing)

URL

[https://www.wipo.int/en/web/business/assignment-licensing](https://www.wipo.int/en/web/business/assignment-licensing)

Publisher

World Intellectual Property Organization
[Trade Secrets](https://www.wipo.int/en/web/trade-secrets)

URL

[https://www.wipo.int/en/web/trade-secrets](https://www.wipo.int/en/web/trade-secrets)

Publisher

World Intellectual Property Organization
[Frequently Asked Questions: Trade Secrets](https://www.wipo.int/en/web/trade-secrets/tradesecrets_faqs)

URL

[https://www.wipo.int/en/web/trade-secrets/tradesecrets_faqs](https://www.wipo.int/en/web/trade-secrets/tradesecrets_faqs)

Publisher

World Intellectual Property Organization
FAQ
## Frequently asked questions

### Does paying for custom development give me formula ownership?

Payment alone does not establish which IP rights have been transferred. WIPO distinguishes assignment, which transfers ownership, from licensing, which permits use while ownership stays with the owner. Have a lawyer review the actual agreement, identified assets and applicable law. Include the starting base and newly developed work separately rather than relying on the word custom.

### Does an NDA let me move production to another manufacturer?

Do not infer manufacturing permission from an NDA. Check which disclosures and uses the documents allow, including access by a receiving manufacturer. WIPO describes confidentiality as part of protecting trade secrets, while licensing concerns permission to use IP. Your lawyer must review how those terms work together under the agreement and applicable jurisdiction.

### Is an exclusive formula licence the same as ownership?

No. A licence can permit exclusive use within its agreed scope while the IP owner retains ownership. WIPO distinguishes sole, exclusive and non-exclusive licensing. Ask counsel to define the covered asset, permitted uses and any territory or term restrictions in your agreement. Separately confirm access to the technical records needed to exercise those rights.

### What should a manufacturing transfer agreement identify?

Identify both the permitted use and the deliverables the receiving team needs. These may include the agreed quantitative formula, material specifications, manufacturing instructions and supporting reports, together with technical assistance and acceptance arrangements. Have legal and technical reviewers check the package separately. Permission to manufacture and the ability to reproduce the product are different questions.

### Can trade-secret protection stop every competing formula?

No. WIPO explains that trade-secret protection does not stop others using information they developed independently or acquired through lawful routes such as reverse engineering, subject to the applicable legal system. Protection also depends on secrecy and reasonable protective steps. Ask counsel which rights and contractual restrictions could protect your project rather than treating confidentiality as guaranteed market exclusivity.

Continue with

[Google](https://cosmetic-labs.com/?lean_auth=start&provider=google&redirect_to=https://cosmetic-labs.com/&error_return=https://cosmetic-labs.com/articles/cosmetic-formula-ownership)
[LinkedIn](https://cosmetic-labs.com/?lean_auth=start&provider=linkedin&redirect_to=https://cosmetic-labs.com/&error_return=https://cosmetic-labs.com/articles/cosmetic-formula-ownership)

© 2026 Cosmetic Labs. All rights reserved.

---

## Site identity

- Organization: Cosmetic Labs
- Description: Cosmetic Labs is a directory and a platform to meet all your cosmetic product development needs. From sourcing raw material to finding the best CRO for your needs.
- Website: https://cosmetic-labs.com

```json
[{"@type":"Article","headline":"Cosmetic Formula Ownership","url":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-formula-ownership","mainEntityOfPage":{"@id":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-formula-ownership#webpage"},"image":{"@type":"ImageObject","url":"https:\/\/cosmetic-labs.com\/wp-content\/uploads\/67010-cosmetic-formula-ownership-1200x1200-1-1024x1024.webp","width":1024,"height":1024,"caption":"Two colleagues discuss a closed document wallet and a small cosmetic prototype at an office table."},"datePublished":"2026-10-23T17:32:26+00:00","dateModified":"2026-10-25T15:34:49+00:00","author":{"@type":"Person","name":"Emilie SCHOL","url":"https:\/\/cosmetic-labs.com\/members\/39984"},"inLanguage":"en-US","publisher":{"@id":"https:\/\/cosmetic-labs.com#organization"},"citation":[{"@type":"CreativeWork","name":"IP Assignment and Licensing","url":"https:\/\/www.wipo.int\/en\/web\/business\/assignment-licensing","publisher":{"@type":"Organization","name":"World Intellectual Property Organization"}},{"@type":"CreativeWork","name":"Trade Secrets","url":"https:\/\/www.wipo.int\/en\/web\/trade-secrets","publisher":{"@type":"Organization","name":"World Intellectual Property Organization"}},{"@type":"CreativeWork","name":"Frequently Asked Questions: Trade Secrets","url":"https:\/\/www.wipo.int\/en\/web\/trade-secrets\/tradesecrets_faqs","publisher":{"@type":"Organization","name":"World Intellectual Property Organization"}}],"@id":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-formula-ownership#article"},{"@type":"WebPage","name":"Cosmetic Formula Ownership","url":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-formula-ownership","mainEntity":{"@id":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-formula-ownership#article"},"isPartOf":{"@id":"https:\/\/cosmetic-labs.com\/articles#webpage"},"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cosmetic-labs.com\/"},{"@type":"ListItem","position":2,"name":"Blog","item":"https:\/\/cosmetic-labs.com\/articles"},{"@type":"ListItem","position":3,"name":"Cosmetic Formula Ownership","item":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-formula-ownership"}]},"inLanguage":"en-US","@id":"https:\/\/cosmetic-labs.com\/articles\/cosmetic-formula-ownership#webpage"}]
```